Irwin Naturals Inc.

    Irwin Naturals Inc.

    OOTC:IWINF
    - -
    USD
    - -
    - -
    2020 Y
    2021 Y
    2022 Y
    TTM
    Revenue per Share
    73.37
    83.62
    62.51
    26.43
    Basic EPS, GAAP
    5.94
    7.18
    -2.79
    -5.89
    Free Cash Flow per Basic Share
    6.64
    9.09
    -4.55
    -1.97
    Dividend per Share
    5.7
    6.72
    - -
    - -
    Book Value per Share
    - -
    14.57
    16.18
    2.17
    Tangible Book Value per Share
    12.05
    19.19
    8.67
    -0.41
    Basic Weighted Avg Shares
    1
    1
    1
    3
    Sales/Revenue/Turnover
    89
    100
    89
    87
    Operating Margin (%)
    8.51
    10.53
    2.06
    -9.03
    Depreciation Expense
    1
    1
    2
    2
    Net Income, GAAP
    7
    9
    -4
    -19
    Effective Tax Rate (%)
    1.58
    - -
    - -
    - -
    Profit Margin (%)
    8.1
    8.59
    -4.46
    -22.3
    Working Capital
    13
    15
    9
    -10
    LT Debt
    1
    2
    3
    8
    Total Equity
    15
    23
    30
    14
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    98.51
    -19.64
    -124.41

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    ST Debt
    33
    33
    33
    LT Borrowings
    8
    7
    6
    LT Finance Leases
    3
    2
    2
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    3
    3
    3
    Market Capitalization
    4
    3
    3

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    Total Current Assets
    48
    46
    38
    Cash, Cash Equivalents & STI
    7
    6
    5
    Accounts Receivable, Net
    16
    16
    13
    Inventories
    22
    21
    17
    Total Current Liabilities
    49
    51
    48
    Payables & Accruals
    13
    17
    14
    ST Debt
    33
    33
    33
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    31.09%
    Free Cash Flow
    - -
    - -
    -159.73%
    Net Income, GAAP
    - -
    - -
    -146.34%
    Sales/Revenue/Turnover
    - -
    - -
    -10.83%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    24
    27
    24
    26
    100
    2022
    23
    22
    22
    23
    89
    2023
    23
    22
    19
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    3.05
    2.44
    -1.34
    - -
    7.18
    2022
    1.12
    0.03
    -0.49
    - -
    -2.79
    2023
    -2.27
    -1.57
    -0.56
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    0.9
    4.51
    1.19
    - -
    6.72
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • globenewswire.com

      Irwin Naturals Reports Q3 2023 Financial Results

    • globenewswire.com

      Irwin Naturals Reports Q2 2023 Financial Results

    • proactiveinvestors.com

      Irwin Naturals launches cannabis tincture products in California

    • globenewswire.com

      Irwin Naturals Unleashes Trio of Cannabis Tinctures in Golden State

    • proactiveinvestors.com

      Irwin Naturals says it made progress in the high-growth cannabis and psychedelics markets in 1Q

    • proactiveinvestors.com

      Irwin Naturals highlights expansion into cannabis and psychedelics sectors as it posts 2022 results

    • proactiveinvestors.com

      Irwin Naturals launches cannabis products nationwide in Canada

    • proactiveinvestors.com

      Irwin Naturals closes acquisition of Ketamine Media owner

    • proactiveinvestors.com

      Braxia Scientific announces termination of Irwin Naturals merger LOI; retains strategic clinical assets

    • proactiveinvestors.com

      Braxia Scientific reports 50.5% increase in 3Q revenue; updates on acquisition by Irwin Naturals

    • proactiveinvestors.com

      Irwin Naturals says it has successfully completed the acquisition of Serenity Health

    • proactiveinvestors.com

      Irwin Naturals secures $40M credit facility to support expansion of psychedelic mental health clinics

    • proactiveinvestors.com

      Irwin Naturals announces LOI to acquire Braxia Scientific to create new market leader

    • proactiveinvestors.com

      Irwin Naturals inks licensing deal to distribute Irwin Naturals cannabis products in Oklahoma

    • proactiveinvestors.ca

      Irwin Naturals an Braxia Scientific partner to accelerate in-human development of new therapies for mental health

    • proactiveinvestors.ca

      Irwin Naturals inks licensing deal to distribute its THC products in Oregon

    • proactiveinvestors.com

      Irwin Naturals completes acquisition of three mental-healthcare clinics in Florida

    • proactiveinvestors.ca

      Irwin Naturals makes progress with its expansion strategy in 3Q

    • proactiveinvestors.com

      Irwin Naturals inks deal to acquire Kentucky-based Serenity Health

    • proactiveinvestors.com

      Irwin Naturals expands network of psychedelic mental healthcare clinics with acquisition of Washington ketamine facility